Atricure reported $58.1M in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Atricure ATRC:US USD 58.1M 64.54M
Baxter International BAX:US USD 1.72B 117M
Becton, Dickinson and BDX:US USD 612M 394M
Cardiovascular Systems CSII:US USD 59.84M 3.01M
Cooper Companies COO:US USD 118.2M 20M
Cryolife CRY:US USD 39.35M 1.78M
Dexcom DXCM:US USD 642.3M 55.8M
Edwards Lifesciences EW:US USD 769M 478.8M
Globus Medical GMED:US USD 150.47M 16.24M
Inogen INGN:US USD 187.01M 22.62M
Insulet PODD:US USD 487.3M 66.1M
Integra Lifesciences IART:US USD 456.66M 55.28M
Intuitive Surgical ISRG:US USD 6.74B 5.74B
Masimo MASI:US USD 202.9M 16.6M
Medtronic MDT:US USD 4.52B 307M
Merit Medical Systems MMSI:US USD 58.41M 6.93M
Nuvasive NUVA:US USD 248.66M 11.16M
Resmed RMD:US USD 253.2M 46.04M
Stryker SYK:US USD 1.84B 424M
Tandem Diabetes Care TNDM:US USD 172.52M 48.73M
Teleflex TFX:US USD 292.03M 105.22M
Zimmer Biomet Holdings Inc ZBH:US USD 375.7M 169.7M